98%
921
2 minutes
20
Amyotrophic lateral sclerosis (ALS) involves both upper motor neurons (UMNs) and lower motor neurons. The detection of UMN involvement, a core component of ALS criteria, is primarily dependent on neurological examination because of a lack of definitive biomarkers. We present the 18F-THK5351 PET images of a 76-year-old man diagnosed with ALS comorbid with Alzheimer disease, demonstrating marked accumulation of 18F-THK5351 in the bilateral precentral gyri. Because 18F-THK5351 binds to monoamine oxidase B highly expressed in astrocytes, where the neurodegenerative process is ongoing, our case highlights that 18F-THK5351 tracer should be a useful marker for detecting UMN neurodegeneration in ALS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLU.0000000000003456 | DOI Listing |
Rinsho Shinkeigaku
May 2025
Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology.
This manuscript complements the clinical course of the first case of neurosyphilis in our previous report (Kotani. et al. Clin Nuc Med 2024) which highlighted the utility of F-THK5351 positron emission tomography (PET), a marker of astrogliosis, to visualize neuroinflammation.
View Article and Find Full Text PDFNeuroimage Clin
June 2025
Department of Nuclear Medicine, Ludwig-Maximilian-University Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
Objectives: Partial volume effects in positron emission tomography occur frequently in neurodegenerative diseases due to increasing cortical atrophy during the disease course, and fronto-temporal dementia is often characterized by severe atrophy. The aim of this study was to challenge partial volume effect correction (PVEC) in patients with nonfluent-agrammatic variant primary progressive aphasia (nfv-PPA) imaged with [F]-THK-5351 PET a marker of reactive neuroinflammatory astrogliosis as well as tau-binding.
Methods: Patients with nfv-PPA (n = 20) were imaged with [F]-THK-5351 PET accompanied by structural magnetic resonance tomography imaging (MRI).
Clin Nucl Med
April 2025
Departments of Radiology.
18F-THK5351 was developed as a tracer with high binding affinity and selectivity for tau protein. However, its off-target binding to monoamine oxidase B (MAO-B), an enzyme highly expressed in astrocytes, has also been demonstrated. In the case of glioblastoma, a strong accumulation of both 11C-methionine (MET) and 18F-THK5351 was observed in the tumor.
View Article and Find Full Text PDFClin Nucl Med
December 2024
From the Department of Neurological Surgery, Faculty of Medicine, Kagawa University.
A teenager who suffered from left hemiparesis after traumatic brain injury underwent 18F-THK5351 PET 48, 286, and 810 days after the injury. The first scan showed slight uptake in the right corticospinal tract (CST), and the second scan showed intense uptake along the CST, which was significantly reduced in the third scan. The hemiparesis has improved between the first and second scans.
View Article and Find Full Text PDFClin Nucl Med
December 2024
From the Department of Neurology.
18 F-labeled THK5351 PET can visualize ongoing astrogliosis by estimating monoamine oxidase B levels and can be used as a neuroinflammation marker for identifying inflammatory lesions by imaging astrogliosis. Assessment of its performance is of interest, especially when compared with conventional MRI. Here, we present 2 cases of neurosyphilis, in which 18 F-THK5351 PET identified inflammatory lesions by imaging astrogliosis, whereas MRI had difficulty detecting the lesions.
View Article and Find Full Text PDF